M01.X9 identifies direct microbial invasion of multiple joints as a manifestation of an underlying infectious or parasitic disease that is coded and classified elsewhere in ICD-10-CM.
Verified May 8, 2026 · 5 sources ↓
- Status
- Billable
- Chapter
- 13
- Related CPT
- 7
- Region
- Multi-region
Documentation tips
What should appear in the chart to support M01.X9.
Source · Editorial brief grounded in 5 cited references ↓
- Identify and document the underlying infectious or parasitic disease by name and confirmed pathogen — this code is the causal sequencing anchor for M01.X9.
- List every affected joint explicitly in the note; 'polyarthritis' alone is insufficient — payers and auditors expect specific joint enumeration to support the 'multiple' designation.
- Record culture, serology, or biopsy results that confirm direct joint infection (not reactive or postinfective arthropathy), since that distinction drives code selection.
- Document the clinical basis for ruling out excluded conditions (Lyme, gonococcal, tuberculous arthritis, etc.) if the presentation is ambiguous, to defend code choice on audit.
- Note the acuity and trajectory of each joint — swelling, warmth, effusion, range-of-motion loss — to support medical necessity for any joint aspiration, imaging, or surgical procedure billed alongside this diagnosis.
Related CPT procedures
Procedure codes commonly billed with M01.X9. Linking the right diagnosis to the right procedure is what establishes medical necessity.
Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis
Common coding pitfalls
The recurring mistakes coders make with M01.X9 and adjacent codes.
Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓
- Sequencing M01.X9 as the principal diagnosis — it is a manifestation code; the underlying infectious/parasitic disease must be listed first per the 'Code first' instruction at M01.
- Applying M01.X9 when the arthropathy is reactive or postinfective rather than caused by direct microbial invasion of the joint — those cases belong under M02 (postinfective and reactive arthropathies).
- Using M01.X9 for conditions explicitly excluded from M01, such as Lyme arthritis (A69.23), gonococcal arthritis (A54.42), or tuberculosis arthritis (A18.01-A18.02), which carry their own codes under the infectious disease chapter.
- Defaulting to M01.X9 when only one joint is infected — the subcategory provides site-specific codes (M01.X11-M01.X79) that should be used for single-joint involvement and are more precise.
- Failing to capture both the underlying disease code and M01.X9 on the claim, leaving the manifestation code unsupported and triggering medical necessity denials.
Clinical context
Source · Editorial summary grounded in 5 cited references ↓
M01.X9 is a manifestation code — it cannot stand alone on a claim. The underlying infectious or parasitic disease must be sequenced first (e.g., leprosy A30.-, mycoses B35-B49, O'nyong-nyong fever A92.1, paratyphoid fever A01.1-A01.4). The joint pathology is a downstream consequence of that primary infection, not a primary diagnosis in its own right.
Use M01.X9 specifically when the documented infection involves multiple joints simultaneously and the causative organism falls within the 'infectious and parasitic diseases' chapter (A00-B99) but the condition is not one of the explicitly excluded entities. Check the Excludes1 list at M01 carefully before assigning: Lyme disease arthropathy (A69.23), gonococcal arthritis (A54.42), meningococcal arthritis (A39.83), mumps arthritis (B26.85), rubella arthritis (B06.82), sarcoidosis arthritis (D86.86), typhoid fever arthritis (A01.04), and tuberculosis arthritis (A18.01-A18.02) all have their own dedicated codes and are excluded from M01.
M01.X9 sits at the end of the M01.X subcategory, which is organized by anatomic site. If the infection is confined to a single named joint, use the site-specific sibling code instead (e.g., M01.X11 for right shoulder, M01.X61 for right knee). Reserve M01.X9 for true polyarticular involvement — two or more distinct joints — where the clinical record explicitly documents multiple joint sites.
Sibling codes
Other billable codes under M01.X (laterality / anatomic variants).
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Does M01.X9 require a companion code?
02How many joints need to be infected to use M01.X9 instead of a site-specific M01 code?
03Can I use M01.X9 for Lyme arthritis affecting multiple joints?
04What is the difference between M01.X9 and M02 codes?
05Is M01.X9 appropriate for septic arthritis of multiple joints caused by Staphylococcus aureus?
06How does M01.X9 differ from M01.X8?
07What CPT codes are commonly billed with M01.X9?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CDC ICD-10-CM Tabular List 2026 (effective Oct 1, 2025)
- 02icd10data.comhttps://www.icd10data.com/ICD10CM/Codes/M00-M99/M00-M02/M01-/M01.X9
- 03aapc.comhttps://www.aapc.com/codes/icd-10-codes/M01.X9
- 04vsac.nlm.nih.govhttps://vsac.nlm.nih.gov/context/cs/codesystem/ICD10CM/version/2023/code/M01.X9/info
- 05cms.govhttps://www.cms.gov/Medicare/Coding/ICD10/Downloads/2019-ICD10-Coding-Guidelines-.pdf
Mira AI Scribe
The Mira AI Scribe captures the specific joints involved, the confirmed (or working) infectious etiology, relevant lab or culture results, and any prior treatment — all of which are required to justify M01.X9 as a manifestation code and to ensure the underlying disease code is sequenced first. Without this context, the claim will lack the causative code pairing required for reimbursement and will flag on audit for incomplete manifestation coding.
See how Mira captures M01.X9 documentation